The Treatment of Cognitive Impairment Associated with Parkinson's Disease
Identifieur interne : 000524 ( Main/Exploration ); précédent : 000523; suivant : 000525The Treatment of Cognitive Impairment Associated with Parkinson's Disease
Auteurs : David J. Burn [Royaume-Uni]Source :
- Brain Pathology [ 1015-6305 ] ; 2010-05.
English descriptors
- KwdEn :
Abstract
Cognitive impairment and dementia associated with Parkinson's disease (PD) are common and often have devastating effects upon the patient and their family. Early cognitive impairment in PD is frequent, and the functional impact may be underestimated. Optimal management will rely upon better identification of the predominant symptoms and greater knowledge of their pathophysiological basis. The management of dementia in PD (PD‐D) also has to consider the significant neuropsychiatric burden that frequently accompanies the cognitive decline, as well as fluctuations in attention. Atypical anti‐psychotics have a limited role at present in treating PD‐D, although new drugs are under development. The mainstay of drug management for people with PD‐D is cholinesterase inhibitors, although recent trials have suggested that the N‐methyl‐D aspartate antagonist memantine may also have some benefit. Disease modification remains the ultimate goal for preventing the inexorable decline in PD‐D, although effective interventions are still some way off. Limited benefit may, however, be possible through exercise programmes and so‐called “medical foods”, although randomised trials are required to confirm largely anecdotal observations.
Url:
DOI: 10.1111/j.1750-3639.2009.00367.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Treatment of Cognitive Impairment Associated with Parkinson's Disease</title><author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:58B163A4903C37C1A8D5738D41B43A9141E18597</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1111/j.1750-3639.2009.00367.x</idno><idno type="url">https://api.istex.fr/document/58B163A4903C37C1A8D5738D41B43A9141E18597/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000410</idno><idno type="wicri:Area/Main/Curation">000355</idno><idno type="wicri:Area/Main/Exploration">000524</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The Treatment of Cognitive Impairment Associated with Parkinson's Disease</title><author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne</wicri:regionArea><wicri:noRegion>Newcastle upon Tyne</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Brain Pathology</title><idno type="ISSN">1015-6305</idno><idno type="eISSN">1750-3639</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2010-05">2010-05</date><biblScope unit="volume">20</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="672">672</biblScope><biblScope unit="page" to="678">678</biblScope></imprint><idno type="ISSN">1015-6305</idno></series><idno type="istex">58B163A4903C37C1A8D5738D41B43A9141E18597</idno><idno type="DOI">10.1111/j.1750-3639.2009.00367.x</idno><idno type="ArticleID">BPA367</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1015-6305</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>cholinesterase inhibitor</term><term>cognitive impairment</term><term>dementia</term><term>memantine</term><term>treatment</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cognitive impairment and dementia associated with Parkinson's disease (PD) are common and often have devastating effects upon the patient and their family. Early cognitive impairment in PD is frequent, and the functional impact may be underestimated. Optimal management will rely upon better identification of the predominant symptoms and greater knowledge of their pathophysiological basis. The management of dementia in PD (PD‐D) also has to consider the significant neuropsychiatric burden that frequently accompanies the cognitive decline, as well as fluctuations in attention. Atypical anti‐psychotics have a limited role at present in treating PD‐D, although new drugs are under development. The mainstay of drug management for people with PD‐D is cholinesterase inhibitors, although recent trials have suggested that the N‐methyl‐D aspartate antagonist memantine may also have some benefit. Disease modification remains the ultimate goal for preventing the inexorable decline in PD‐D, although effective interventions are still some way off. Limited benefit may, however, be possible through exercise programmes and so‐called “medical foods”, although randomised trials are required to confirm largely anecdotal observations.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000524 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000524 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:58B163A4903C37C1A8D5738D41B43A9141E18597
|texte= The Treatment of Cognitive Impairment Associated with Parkinson's Disease
}}
| This area was generated with Dilib version V0.6.23. |  |